News

Brain tumors are among the deadliest forms of cancer, due in large part to their sensitive location and the challenge of performing surgery to remove them. New research led by David Solomon,MD, PhD, an assistant professor in the Department of Pathology at UC San Francisco, provides much-needed

Prostate cancer imposes a disproportionate burden on African American men. This population has a 63% higher incidence rate than white men, and they tend to be diagnosed with more aggressive disease and report more side effects from treatment. They also die at twice the rate as white men. Part of the

A new UC San Francisco study has shown that a cancer-killing (“oncolytic”) virus currently in clinical trials may function as a cancer vaccine — in addition to killing some cancer cells directly, the virus alerts the immune system to the presence of a tumor, triggering a powerful, widespread immune

California already has the nation’s largest medical marijuana market, and this year is expected to have the world’s largest recreational market. With enormous potential to influence policy, the state should take an assertive approach to cannabis labeling, packaging and product formulation, according

Prostate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In these survivors, early detection of recurrence can lead to life-saving interventions, but in older men who survived low-risk cancer and have limited life expectancy, those same interventions may do more

Treatment with an investigational androgen receptor inhibitor significantly delayed the development of metastasis in patients with prostate cancer that had become resistant to standard androgen-deprivation therapy. The results of a multi-institutional, phase 3 clinical trial of apalutamide – led by

Helen and Sanford Diller: A Legacy of Philanthropy and Purpose The faculty and staff at the Helen Diller Family Comprehensive Cancer Center are among the many people saddened by the passing of Sanford Diller, a longtime friend and champion of UCSF and the Cancer Center. Support from Sanford Diller